☆ 4.5 Article

Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece

VACCINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Public, Environmental & Occupational Health

Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance

Ashley L. O'Leary et al.

Summary: This study suggests that advanced age >= 65 is the greatest risk factor for mortality in hospitalized COVID-19 patients. COVID-19 vaccination, especially booster doses, is associated with a decreased risk of 14-day mortality compared to double vaccinated or non-vaccinated patients. These findings indicate that advanced age should be prioritized for COVID-19 treatments during Omicron.

AMERICAN JOURNAL OF INFECTION CONTROL (2023)

添加到收藏夹

Article Immunology

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

Paul T. Heath et al.

Summary: In a phase 3 trial, a 2-dose regimen of the NVX-CoV2373 vaccine provided a high level of protection against asymptomatic, symptomatic, and severe COVID-19 for more than 6 months postvaccination. The vaccine showed 100% efficacy against severe disease and 76.3% efficacy against asymptomatic disease.

CLINICAL INFECTIOUS DISEASES (2023)

添加到收藏夹

Editorial Material Medicine, General & Internal

Who wants his dose?

[Anonymous]

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance — One Hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022

Matthew E Modes et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

添加到收藏夹

Editorial Material Infectious Diseases

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era

Stephen Y. Wang et al.

LANCET MICROBE (2022)

添加到收藏夹

Article Immunology

How Drivers of Seasonality in Respiratory Infections May Impact Vaccine Strategy: A Case Study in How Coronavirus Disease 2019 (COVID-19) May Help Us Solve One of Influenza's Biggest Challenges

Eric T. Lofgren et al.

Summary: Vaccines against seasonal infections like influenza provide a crucial testbed for understanding seasonal outbreak patterns, driving factors, and improving vaccine strategies to enhance global health outcomes.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Letter Infectious Diseases

High rate of reinfection with the SARS-CoV-2 Omicron variant

Nhu Ngoc Nguyen et al.

JOURNAL OF INFECTION (2022)

添加到收藏夹

Article Immunology

Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers

Anastasia Saade et al.

Summary: A study conducted at the University Hospital of Rennes in France found that the incidence of SARS-CoV-2 infection increases over time in fully vaccinated healthcare workers, with age being independently associated with the incidence of infection and vaccination schemes not affecting infection rates.

VACCINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar

Hiam Chemaitelly et al.

Summary: mRNA COVID-19 vaccines provide moderate and short-lived protection against symptomatic Omicron BA.1 and BA.2 infections, but strong and durable protection against COVID-19 hospitalization and death.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review

Yuxuan Du et al.

Summary: There is growing evidence suggesting that the effectiveness of existing vaccines against the Omicron variant is significantly reduced with only primary vaccination. This study aimed to investigate the effectiveness of booster vaccination against the Omicron variant through neutralization tests. The results showed that booster vaccination can significantly enhance the neutralization of serum antibodies against the Omicron variant, although the levels are still lower compared to the original strain and other variants.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

添加到收藏夹

Article Immunology

Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study

Francesco Paolo Bianchi et al.

Summary: A study in Italy found that antibodies in healthcare workers remain stable over the medium-to-long term after completing the vaccination cycle, with over 99% of workers still protected. However, older subjects seem to lose antibodies faster than younger ones.

VACCINES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Acute and postacute sequelae associated with SARS-CoV-2 reinfection

Benjamin Bowe et al.

Summary: A new analysis using US Department of Veterans Affairs databases showed that reinfection is associated with increased risk of all-cause mortality, hospitalization and a wide range of long COVID complications in individuals who have had SARS-CoV-2 compared to those with no reinfection.

NATURE MEDICINE (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

Hannah G. Rosenblum et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

添加到收藏夹

Review Virology

Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission

Lok Bahadur Shrestha et al.

Summary: The Omicron variant of SARS-CoV-2 is a major public health concern due to its high infectivity and antibody evasion. It has rapidly become the dominant variant worldwide and has evolved through several variants. The evolution of Omicron is thought to be influenced by zoonotic spillage, infection in immunocompromised individuals, and undiagnosed spread in the community. Current research suggests that Omicron is more infectious than the original Wuhan-Hu-1 and Delta variants, but less severe in terms of its impact on lung tissue. Vaccines have shown reduced effectiveness against Omicron, but booster shots can improve efficacy. Broadly neutralizing monoclonal antibodies have limited effectiveness against Omicron, with some exceptions. New variants, such as BA.4 and BA.5, are emerging and are reported to be more transmissible and resistant to immunity generated by previous variants and monoclonal antibodies.

REVIEWS IN MEDICAL VIROLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era

George N. Ioannou et al.

Summary: This study investigates the effectiveness of a third mRNA COVID-19 vaccine dose (booster dose) against the Omicron variant. The results show that booster mRNA vaccination is highly effective in preventing death and moderately effective in preventing infection and hospitalization in the Omicron era.

ANNALS OF INTERNAL MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021

Jostein Starrfelt et al.

Summary: This population-based cohort study evaluated the vaccine effectiveness of different COVID-19 vaccine regimens against SARS-CoV-2 infections, hospitalizations, intensive care admissions, and death. The results showed that the overall adjusted vaccine effectiveness against infection decreased over time, but remained effective against hospitalization. A booster dose significantly increased the effectiveness. Spikevax or a combination of mRNA products provided the highest protection.

BMC MEDICINE (2022)

添加到收藏夹

Editorial Material Infectious Diseases

Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control

Shui Shan Lee et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Immunology

Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort

Ida Laake et al.

Summary: Understanding how booster vaccination can prevent moderate and severe illness without hospitalization is crucial to evaluate the full advantage of mRNA boosters. In this population-based study, mRNA booster vaccination partly prevented moderate and severe COVID-19, but not mild COVID-19. The effectiveness of booster vaccination increased with increasing severity of COVID-19 and decreased with time since booster vaccination. The findings contribute valuable information on the duration of protection and timing of additional booster vaccinations.

JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Immunology

Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection

Loukia Psaridi et al.

Summary: This study aimed to assess the neutralizing antibody immunity against SARS-CoV-2 in healthcare personnel vaccinated with three doses of the BNT162b2 mRNA vaccine. The results showed that the neutralizing antibody levels significantly increased after receiving the booster dose of the vaccine. Younger individuals and those with previous SARS-CoV-2 infection had higher antibody levels, while there was an inverse correlation between antibody levels and comorbidities or tobacco use. At the end of the study period, an increase in neutralizing antibody titers was observed in women.

VACCINE (2022)

添加到收藏夹

Article Immunology

Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study

Helena C. Maltezou et al.

Summary: This study assessed the impact of COVID-19 vaccination status and time elapsed since the last vaccine dose on morbidity and absenteeism among healthcare personnel. The results showed that fully vaccinated individuals had shorter absenteeism and receiving a booster dose within four months of the last vaccine dose provided significant protection against COVID-19 infection.

VACCINE (2022)

添加到收藏夹

Review Environmental Sciences

Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis

Jie Deng et al.

Summary: Based on the available data, both homologous and heterologous COVID-19 booster doses have high effectiveness and immunogenicity, with acceptable safety. Heterologous booster doses are more effective than homologous ones, which can help inform public health decisions and reduce vaccine hesitancy.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

添加到收藏夹

Article Infectious Diseases

COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups

Sherrie L. Kelly et al.

Summary: According to the model, timely administration of COVID-19 vaccine boosters to eligible individuals, prioritizing the most vulnerable, can reduce infections and hospital admissions. These findings provide evidence-based guidance for decision-makers to plan for administering COVID-19 boosters ahead of winter 2022-2023 to mitigate the health burden and stress on the healthcare system.

INFECTIOUS DISEASES AND THERAPY (2022)

添加到收藏夹

Article Environmental Sciences

Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain

Narmeen Mallah et al.

Summary: Research shows that COVID-19 booster vaccines can significantly increase protection against SARS-CoV-2 infection, especially in older age groups and those with various medical conditions.

ENVIRONMENTAL RESEARCH (2022)

添加到收藏夹

Review Critical Care Medicine

Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU A Systematic Review and Meta-analysis

Elinor Tan et al.

Summary: The systematic review and meta-analysis included 45 studies from 17 countries across four continents, involving 16,561 patients with severe COVID-19 admitted to ICUs. The study revealed that critically ill COVID-19 patients require substantial organ support, with a high mortality rate of 28.1% during hospitalization.

CHEST (2021)

添加到收藏夹

Article Virology

Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters

Rachel M. Burckhardt et al.

JOURNAL OF VIROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Years of life lost to COVID-19 in 81 countries

Hector Pifarre i Arolas et al.

Summary: The study reveals a significant loss of years of life due to COVID-19 globally, especially in heavily affected countries. The majority of these lost years are from deaths under 75 years old, particularly those under 55, with men losing 45% more life years than women. These findings emphasize the need for policies that protect vulnerable demographics with the highest loss of life-years.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Immunology

COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study

Helena C. Maltezou et al.

Summary: This study assessed the impact of the PfizerBioNTech vaccine on morbidity and absenteeism among healthcare personnel in Greece. The results showed that vaccination significantly reduced morbidity, COVID-19, absenteeism, and duration of absenteeism among healthcare personnel, demonstrating the vaccine's effectiveness in protecting this group and maintaining healthcare services.

VACCINE (2021)

添加到收藏夹

Letter Public, Environmental & Occupational Health

Coronavirus disease 2019 pandemic in Greece, February 26-May 3, 2020: The first wave

Helena C. Maltezou et al.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2021)

添加到收藏夹

Editorial Material Immunology

Influenza immunization and COVID-19

Helena C. Maltezou et al.

VACCINE (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.